Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Ixekizumab (I1F-MC-B005)

29/01/2018
07/01/2026
EU PAS number:
EUPAS15481
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

ELI_Pregnancy_Safety_Protocol_Redacted

English (439.29 KB - PDF) View document
Updated protocol

B005 PASS(2)_Redacted

First published: 22/02/2024
English (776.84 KB - PDF) View document
Study results
Study report
Other information